2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the …
A Vahanian, F Beyersdorf, F Praz… - European heart …, 2022 - academic.oup.com
Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …
when exercising their clinical judgment, as well as in the determination and the …
[HTML][HTML] T2 mapping in myocardial disease: a comprehensive review
Cardiovascular magnetic resonance (CMR) is considered the gold standard imaging
modality for myocardial tissue characterization. Elevated transverse relaxation time (T2) is …
modality for myocardial tissue characterization. Elevated transverse relaxation time (T2) is …
Electrocardiogram screening for aortic valve stenosis using artificial intelligence
M Cohen-Shelly, ZI Attia, PA Friedman… - European heart …, 2021 - academic.oup.com
Aims Early detection of aortic stenosis (AS) is becoming increasingly important with a better
outcome after aortic valve replacement in asymptomatic severe AS patients and a poor …
outcome after aortic valve replacement in asymptomatic severe AS patients and a poor …
2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the …
F Beyersdorf, A Vahanian, M Milojevic… - European journal of …, 2021 - academic.oup.com
731 F. Beyersdorf and A. Vahanian et al./European Journal of Cardio-Thoracic Surgery
guidelines, which is freely available via the ESC and EACTS website and hosted on the EHJ …
guidelines, which is freely available via the ESC and EACTS website and hosted on the EHJ …
Impact of myocardial fibrosis on left ventricular remodelling, recovery, and outcome after transcatheter aortic valve implantation in different haemodynamic subtypes of …
M Puls, BE Beuthner, R Topci… - European heart …, 2020 - academic.oup.com
Aims Myocardial fibrosis (MF) might represent a key player in pathophysiology of heart
failure in aortic stenosis (AS). We aimed to assess its impact on left ventricular (LV) …
failure in aortic stenosis (AS). We aimed to assess its impact on left ventricular (LV) …
Multimodality imaging assessment of myocardial fibrosis
Myocardial fibrosis, seen in ischemic and nonischemic cardiomyopathies, is associated with
adverse cardiac outcomes. Noninvasive imaging plays a key role in early identification and …
adverse cardiac outcomes. Noninvasive imaging plays a key role in early identification and …
Myocardial fibrosis: why image, how to image and clinical implications
The current era has seen major advances in myocardial imaging. We are now able to
assess cardiac anatomy, function, tissue composition and disease activity across a wide …
assess cardiac anatomy, function, tissue composition and disease activity across a wide …
IL‐11 in cardiac and renal fibrosis: late to the party but a central player
Fibrosis is a pathophysiological hallmark of cardiorenal disease. In the heart, fibrosis leads
to contractile dysfunction and arrhythmias; in the kidney, it is the final common pathway for …
to contractile dysfunction and arrhythmias; in the kidney, it is the final common pathway for …
Pathophysiology of aortic stenosis and future perspectives for medical therapy
Calcific aortic stenosis (AS) is the most common valve disease in the high-income countries
and is set to become a major health care burden with an aging population. 1 It is …
and is set to become a major health care burden with an aging population. 1 It is …
Evaluation and management of aortic stenosis in chronic kidney disease: a scientific statement from the American Heart Association
Aortic stenosis with concomitant chronic kidney disease (CKD) represents a clinical
challenge. Aortic stenosis is more prevalent and progresses more rapidly and unpredictably …
challenge. Aortic stenosis is more prevalent and progresses more rapidly and unpredictably …